{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:00:25Z","timestamp":1772164825100,"version":"3.50.1"},"reference-count":90,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Substantial evidence links higher adiposity to prostate cancer development. The relationship between adiposity and outcomes after a prostate cancer diagnosis, however, is unclear. This study aimed to investigate the association between adiposity measured close to prostate cancer diagnosis and all-cause and prostate cancer\u2013specific mortality in a prospective cohort study. Cox regression analyses estimated HRs and 95% confidence intervals (CI) for mortality in 3,760 men in the UK Biobank who had first primary prostate cancer and complete data on body mass index (BMI), waist circumference, hip circumference, waist-to-hip ratio (measured up to 2 years before or up to 5 years after diagnosis), and on covariates (diagnosis age and year, smoking, Townsend deprivation index, exercise, sedentary activities, and alcohol). The waist-to-height ratio and body fat percentage (assessed by bioelectrical impedance) were also evaluated as adiposity measures. Each 5-U increment in pre- or post-diagnosis BMI (N = 3,760) was associated with a 30% (95% CI, 1.18\u20131.44) higher rate of all-cause mortality (deaths = 680), a 33% (95% CI, 1.15\u20131.52) higher rate of prostate cancer\u2013specific mortality (deaths = 331), and a 28% (95% CI, 1.12\u20131.47) higher rate of non\u2013prostate cancer mortality (deaths = 347). Positive associations of similar magnitude were observed for separate analyses by pre- and post-diagnosis BMI and for waist and hip circumference, waist-to-hip ratio, waist-to-height ratio, and body fat percentage. Obesity assessed close to prostate cancer diagnosis is associated with higher mortality. More studies are needed to strengthen the evidence and clarify the mechanisms behind the observed associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Patients with prostate cancer might improve their chances of survival by avoiding obesity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0124","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T07:11:06Z","timestamp":1751008266000},"page":"1155-1170","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adiposity Status Close to Diagnosis and Its Association with Prostate Cancer Survival in the UK Biobank"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2660-7866","authenticated-orcid":false,"given":"Margarita","family":"Cariolou","sequence":"first","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-4436","authenticated-orcid":false,"given":"Sofia","family":"Christakoudi","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-6761","authenticated-orcid":false,"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-1300","authenticated-orcid":false,"given":"Alicia K.","family":"Heath","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7332-8387","authenticated-orcid":false,"given":"Amy","family":"Berrington de Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."},{"name":"2Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-1897","authenticated-orcid":false,"given":"Doris S.M.","family":"Chan","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2350-0417","authenticated-orcid":false,"given":"David C.","family":"Muller","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-8472","authenticated-orcid":false,"given":"Konstantinos K.","family":"Tsilidis","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom."},{"name":"3Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025071604535148600_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025071604535148600_bib2","article-title":"Global cancer observatory - data version: Globocan 2022 - 08.02.2024"},{"key":"2025071604535148600_bib3","article-title":"Cancer Research UK"},{"key":"2025071604535148600_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025071604535148600_bib5","first-page":"28","article-title":"Epidemiology, staging and management of prostate cancer","volume":"8","author":"Barsouk","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"2025071604535148600_bib6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3390\/nu15173860","article-title":"Post-diagnosis dietary patterns among cancer survivors in relation to all-cause mortality and cancer-specific mortality: a systematic review and meta-analysis of cohort studies","volume":"15","author":"Spei","year":"2023","journal-title":"Nutrients"},{"key":"2025071604535148600_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1878-0261.12428","article-title":"Cancer survivorship: an integral part of Europe\u2019s research agenda","volume":"13","author":"Lagergren","year":"2019","journal-title":"Mol Oncol"},{"key":"2025071604535148600_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3322\/caac.21719","article-title":"American Cancer Society nutrition and physical activity guideline for cancer survivors","volume":"72","author":"Rock","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2025071604535148600_bib9","article-title":"Diet, nutrition, physical activity and cancer: a global perspective. Continuous update project report","author":"World Cancer Research Fund International\/American Institute for Cancer Research","year":"2018"},{"key":"2025071604535148600_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer Epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"2025071604535148600_bib11","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.19.02185","article-title":"Postdiagnosis body mass index, weight change, and mortality from prostate cancer, cardiovascular disease, and all causes among survivors of nonmetastatic prostate cancer","volume":"38","author":"Troeschel","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025071604535148600_bib12","doi-asserted-by":"crossref","first-page":"e000339","DOI":"10.1136\/bmjmed-2022-000339","article-title":"Association between adiposity after diagnosis of prostate cancer and mortality: systematic review and meta-analysis","volume":"2","author":"Cariolou","year":"2023","journal-title":"BMJ Med"},{"key":"2025071604535148600_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12916-017-0876-7","article-title":"Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study","volume":"15","author":"Perez-Cornago","year":"2017","journal-title":"BMC Med"},{"key":"2025071604535148600_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ije\/dyz235","article-title":"Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample mendelian-randomization study based on 79 148 prostate-cancer cases and 61106 controls","volume":"49","author":"Kazmi","year":"2020","journal-title":"Int J Epidemiol"},{"key":"2025071604535148600_bib15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","article-title":"Body mass index and incidence of localized and advanced prostate cancer\u2013a dose-response meta-analysis of prospective studies","volume":"23","author":"Discacciati","year":"2012","journal-title":"Ann Oncol"},{"key":"2025071604535148600_bib16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"2025071604535148600_bib17","article-title":"Diet, nutrition, physical activity, and prostate cancer","author":"World Cancer Research Fund International\/American Institute for Cancer Research Continuous Update Project Report","year":"2018"},{"key":"2025071604535148600_bib18","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1158\/1055-9965.EPI-08-0609","article-title":"Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition","volume":"17","author":"Pischon","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025071604535148600_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12916-022-02336-x","article-title":"Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies","volume":"20","author":"Perez-Cornago","year":"2022","journal-title":"BMC Med"},{"key":"2025071604535148600_bib20","doi-asserted-by":"crossref","first-page":"pkae070","DOI":"10.1093\/jncics\/pkae070","article-title":"Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study","volume":"8","author":"Cariolou","year":"2024","journal-title":"JNCI Cancer Spectr"},{"key":"2025071604535148600_bib21","article-title":"UK Biobank"},{"key":"2025071604535148600_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","article-title":"What makes UK Biobank special?","volume":"379","author":"Collins","year":"2012","journal-title":"Lancet"},{"key":"2025071604535148600_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"2025071604535148600_bib24","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025071604535148600_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41416-022-02053-5","article-title":"UK Biobank: a globally important resource for cancer research","volume":"128","author":"Conroy","year":"2023","journal-title":"Br J Cancer"},{"key":"2025071604535148600_bib26","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"2025071604535148600_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/2212697X0101131204151357","article-title":"Castration Resistant Prostate Cancer: from emerging molecular pathways to targeted therapeutic approaches","volume":"1","author":"Limonta","year":"2014","journal-title":"Clin Cancer Drugs"},{"key":"2025071604535148600_bib28","first-page":"143","article-title":"Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer","volume":"4","author":"Chetta","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"2025071604535148600_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"2025071604535148600_bib30","article-title":"UK Biobank Coordinating Centre; UK Biobank: Protocol for a large-scale prospective epidemiological resource","journal-title":"Protocol No: UKBB-PROT-09\u201306 (Main Phase); 21 March 2007 (AMENDMENT ONE FINAL)"},{"key":"2025071604535148600_bib31","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ije\/dyz032","article-title":"Accounting for missing data in statistical analyses: multiple imputation is not always the answer","volume":"48","author":"Hughes","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2025071604535148600_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"2025071604535148600_bib33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"Compendium of physical activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"2025071604535148600_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annepidem.2015.01.015","article-title":"Physical activity in relation to body size and composition in women in UK Biobank","volume":"25","author":"Guo","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"6 Suppl","key":"2025071604535148600_bib35","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1097\/00005768-200106001-00005","article-title":"Type of activity: resistance, aerobic and leisure versus occupational physical activity","volume":"33","author":"Howley","year":"2001","journal-title":"Med Sci Sports Exerc"},{"key":"2025071604535148600_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2288-11-97","article-title":"Reported frequency of physical activity in a large epidemiological study: relationship to specific activities and repeatability over time","volume":"11","author":"Armstrong","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2025071604535148600_bib37","doi-asserted-by":"crossref","first-page":"e011843","DOI":"10.1136\/bmjopen-2016-011843","article-title":"Association between physical activity and body fat percentage, with adjustment for BMI: a large cross-sectional analysis of UK Biobank","volume":"7","author":"Bradbury","year":"2017","journal-title":"BMJ Open"},{"key":"2025071604535148600_bib38","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.3390\/ijerph17145178","article-title":"Is there a link between different types of alcoholic drinks and obesity? An analysis of 280,183 UK Biobank participants","volume":"17","author":"Inan-Eroglu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025071604535148600_bib39","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1473-3099(20)30978-6","article-title":"Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study","volume":"21","author":"Drozd","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025071604535148600_bib40","doi-asserted-by":"crossref","DOI":"10.4324\/9781003368885","volume-title":"Health and deprivation: inequality and the North","author":"Townsend","year":"2023"},{"key":"2025071604535148600_bib41","article-title":"UK Biobank touch-screen questionnaire: final version"},{"key":"2025071604535148600_bib42","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1002\/cam4.4097","article-title":"A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort","volume":"10","author":"Christakoudi","year":"2021","journal-title":"Cancer Med"},{"key":"2025071604535148600_bib43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2025071604535148600_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"2025071604535148600_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-319-19425-7_2","article-title":"General aspects of fitting regression models","volume-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"Harrell","year":"2015"},{"key":"2025071604535148600_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"2025071604535148600_bib47","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer","volume":"34","author":"Halabi","year":"2016","journal-title":"J Clin Oncol"},{"key":"2025071604535148600_bib48","doi-asserted-by":"crossref","first-page":"e0227552","DOI":"10.1371\/journal.pone.0227552","article-title":"Overall survival and second primary malignancies in men with metastatic prostate cancer","volume":"15","author":"Meht\u00e4l\u00e4","year":"2020","journal-title":"PLoS One"},{"key":"2025071604535148600_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12014-020-09305-7","article-title":"Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management","volume":"17","author":"Tonry","year":"2020","journal-title":"Clin Proteomics"},{"key":"2025071604535148600_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ijc.34904","article-title":"Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading","volume":"155","author":"Tsilidis","year":"2024","journal-title":"Int J Cancer"},{"key":"2025071604535148600_bib51","doi-asserted-by":"crossref","first-page":"112494","DOI":"10.1016\/j.nut.2024.112494","article-title":"Advancing body composition assessment in patients with cancer: first comparisons of traditional versus multicompartment models","volume":"125","author":"Bennett","year":"2024","journal-title":"Nutrition"},{"key":"2025071604535148600_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/pros.23001","article-title":"Body mass index and mortality in men with prostate cancer","volume":"75","author":"Cantarutti","year":"2015","journal-title":"Prostate"},{"key":"2025071604535148600_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/JU.0000000000001428","article-title":"Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and\/or castrate-resistant prostate cancer","volume":"205","author":"Xu","year":"2021","journal-title":"J Urol"},{"key":"2025071604535148600_bib54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bju.14193","article-title":"Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database","volume":"122","author":"Vidal","year":"2018","journal-title":"BJU Int"},{"key":"2025071604535148600_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41391-021-00418-0","article-title":"The obesity paradox in metastatic castration-resistant prostate cancer","volume":"25","author":"Martini","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2025071604535148600_bib56","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/bjc.2017.440","article-title":"Anthropometric measurements and survival after a prostate cancer diagnosis","volume":"118","author":"Farris","year":"2018","journal-title":"Br J Cancer"},{"key":"2025071604535148600_bib57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10552-020-01306-z","article-title":"Central adiposity at diagnosis may reduce prostate cancer-specific mortality in African-Caribbean men with prostate cancer: 10-year follow-up of participants in a case-control study","volume":"31","author":"Jackson","year":"2020","journal-title":"Cancer Causes Control"},{"key":"2025071604535148600_bib58","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.30803","article-title":"Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer","volume":"141","author":"Dickerman","year":"2017","journal-title":"Int J Cancer"},{"key":"2025071604535148600_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.juro.2009.02.118","article-title":"The impact of obesity on overall and cancer specific survival in men with prostate cancer","volume":"182","author":"Davies","year":"2009","journal-title":"J Urol"},{"key":"2025071604535148600_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jdiacomp.2016.02.008","article-title":"The impact of diabetes and other metabolic disorders on prostate cancer prognosis","volume":"30","author":"Polesel","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2025071604535148600_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/oby.2011.142","article-title":"The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat","volume":"20","author":"Thomas","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"2025071604535148600_bib62","doi-asserted-by":"crossref","first-page":"9462975","DOI":"10.1155\/2016\/9462975","article-title":"Fortifying the treatment of prostate cancer with physical activity","volume":"2016","author":"Champ","year":"2016","journal-title":"Prostate Cancer"},{"key":"2025071604535148600_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"2025071604535148600_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/pcan.2015.64","article-title":"Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis","volume":"19","author":"Zhong","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2025071604535148600_bib65","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.3390\/cancers13164169","article-title":"Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients","volume":"13","author":"Rivera-Izquierdo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025071604535148600_bib66","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"2025071604535148600_bib67","doi-asserted-by":"crossref","first-page":"103543","DOI":"10.1016\/j.critrevonc.2021.103543","article-title":"Obesity and prostate cancer: a narrative review","volume":"169","author":"Wilson","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025071604535148600_bib68","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jnci\/djad140","article-title":"The growing implications of obesity for prostate cancer risk and mortality: where do we go from here?","volume":"115","author":"Daniels","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2025071604535148600_bib69","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41416-020-01155-2","article-title":"Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020?","volume":"124","author":"Anderson","year":"2020","journal-title":"Br J Cancer"},{"key":"2025071604535148600_bib70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","article-title":"The obese adipose tissue microenvironment in cancer development and progression","volume":"15","author":"Quail","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2025071604535148600_bib71","first-page":"455","article-title":"Inflammation in prostate cancer progression and therapeutic targeting","volume":"4","author":"Stark","year":"2015","journal-title":"Transl Androl Urol"},{"key":"2025071604535148600_bib72","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1158\/1078-0432.CCR-12-2603","article-title":"Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer","volume":"19","author":"Howe","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2025071604535148600_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm8020201","article-title":"Obesity, inflammation, and prostate cancer","volume":"8","author":"Fujita","year":"2019","journal-title":"J Clin Med"},{"key":"2025071604535148600_bib74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clon.2020.05.004","article-title":"Obesity and cancer treatment outcomes: interpreting the complex evidence","volume":"32","author":"Slawinski","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2025071604535148600_bib75","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1158\/1055-9965.EPI-19-0488","article-title":"Obesity at diagnosis and prostate cancer prognosis and recurrence risk following primary treatment by radical prostatectomy","volume":"28","author":"Langlais","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2025071604535148600_bib76","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"2025071604535148600_bib77","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1113\/JP271757","article-title":"Exercise training improves obesity-related lymphatic dysfunction","volume":"594","author":"Hespe","year":"2016","journal-title":"J Physiol"},{"key":"2025071604535148600_bib78","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1113\/JP273061","article-title":"Obesity-induced lymphatic dysfunction is reversible with weight loss","volume":"594","author":"Nitti","year":"2016","journal-title":"J Physiol"},{"key":"2025071604535148600_bib79","doi-asserted-by":"crossref","first-page":"k2396","DOI":"10.1136\/bmj.k2396","article-title":"Food based dietary patterns and chronic disease prevention","volume":"361","author":"Schulze","year":"2018","journal-title":"BMJ"},{"key":"2025071604535148600_bib80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/CLEP.S97874","article-title":"Challenges in translating endpoints from trials to observational cohort studies in oncology","volume":"8","author":"Ording","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2025071604535148600_bib81","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3390\/cancers12102984","article-title":"Inflammation as a driver of prostate cancer metastasis and therapeutic resistance","volume":"12","author":"Archer","year":"2020","journal-title":"Cancers"},{"key":"2025071604535148600_bib82","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11764-023-01512-z","article-title":"Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature","volume":"19","author":"Lewis","year":"2024","journal-title":"J Cancer Surviv"},{"key":"2025071604535148600_bib83","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clnesp.2024.06.040","article-title":"Comparison of body composition measures assessed by bioelectrical impedance analysis versus dual-energy X-ray absorptiometry in the United Kingdom Biobank","volume":"63","author":"Feng","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"2025071604535148600_bib84","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/djt211","article-title":"Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival","volume":"105","author":"Chubak","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2025071604535148600_bib85","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/jcsm.13256","article-title":"Low muscle mass, malnutrition, sarcopenia, and associations with survival in adults with cancer in the UK Biobank cohort","volume":"14","author":"Kiss","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025071604535148600_bib86","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.33255","article-title":"Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank","volume":"148","author":"Monroy-Iglesias","year":"2021","journal-title":"Int J Cancer"},{"key":"2025071604535148600_bib87","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/ijms19051359","article-title":"Recent advances in prostate cancer treatment and drug discovery","volume":"19","author":"Nevedomskaya","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2025071604535148600_bib88","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41416-023-02526-1","article-title":"Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts","volume":"130","author":"Fritz","year":"2024","journal-title":"Br J Cancer"},{"key":"2025071604535148600_bib89","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10552-015-0624-2","article-title":"The negative impact of tobacco smoking on survival after prostate cancer diagnosis","volume":"26","author":"Polesel","year":"2015","journal-title":"Cancer Causes Control"},{"key":"2025071604535148600_bib90","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/0008-5472.CAN-17-3043","article-title":"The plausibility of obesity paradox in cancer-point","volume":"78","author":"Park","year":"2018","journal-title":"Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0124\/3626896\/crc-25-0124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1155\/3631388\/crc-25-0124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/7\/1155\/3631388\/crc-25-0124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T08:54:05Z","timestamp":1752656045000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/7\/1155\/763567\/Adiposity-Status-Close-to-Diagnosis-and-Its"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0124","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29581000","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581033","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581045","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581012","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581024","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29580991","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581003","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581036","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29580994","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581015","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581027","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29580985","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581006","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581039","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581018","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29580997","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581009","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29580988","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581030","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581042","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29581021","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7930981","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}